Immune therapy should be targeted, not systemic.

Current autoimmune therapies lack precision and increase the risk of serious infections and complications.

Reset Bio is developing technologies to precisely identify and target disease-driving T cells while also preserving a healthy immune function.

Step 1

Map

Culprit Clones

Step 2

Select

Disease-driving cells

Step 3

Deplete

Pathogenic Cells

Thomas Guy

MD PhD

Clinician-scientist building Reset Bio around high-resolution immune profiling and targeted T-cell intervention.

  • Head of the Sydney Translational Immunology Research Program - RPAH

  • Fulbright Fellow - Harvard Medical School